Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steve Myers Insider Profile
4 Followers
Steve Myers, Director at Advanced Oncotherapy, holds 1.61M shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Steve Myers Bought 70,000p shares of Advanced Oncotherapy on Dec 29, 2022 for an estimated value of 8.75K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-21.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Steve Myers does not currently own shares as a corporate insider.
A breakdown of Steve Myers's holdings
Insider Roles
Steve Myers does not currently hold a role as a corporate insider.
Roles that Steve Myers holds in companies
Most Profitable Insider Trade
Stock:
Advanced Oncotherapy
(AVO)
(AVO)
Rating:Informative Buy
Date:May 15, 2017 - May 15, 2018
Return:+103.60%
The most profitable trade made by Steve Myers
Steve Myers's Trading History
List of latest transactions for each holding click on a transaction to see Steve Myers's performance on stock
You May Also Like
Steve Myers insider profile FAQ
What is the percentage of profitable transactions made by Steve Myers?
The percentage of profitable transactions made by Steve Myers is 33%.
What is the average return per transaction made by Steve Myers?
The average return per transaction made by Steve Myers is -21.40%.
What stocks does Steve Myers hold?
Steve Myers holds: GB:AVO stocks.
What was Steve Myers’s latest transaction?
Steve Myers latest transaction was an Informative Buy of 8.75K.
What was Steve Myers's most profitable transaction?
Steve Myers’s most profitable transaction was an Informative Buy of GB:AVO stock on May 15, 2017. The return on the trade was 103.60%.
What is Steve Myers's role in Advanced Oncotherapy?
Steve Myers's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.